Melissa Pinto Selected Research

Antihypertensive Agents (Antihypertensives)

4/2011

Rho kinase inhibition activates the homologous angiotensin-converting enzyme-angiotensin-(1-9) axis in experimental hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Melissa Pinto Research Topics

Disease

3	Hypertrophy 04/2014 - 10/2006
2	Hypertension (High Blood Pressure) 04/2014 - 04/2011
2	Cardiomegaly (Heart Hypertrophy) 05/2010 - 10/2006
2	Myocardial Infarction 05/2010 - 10/2006
1	Fibrosis (Cirrhosis) 04/2014
1	Ventricular Dysfunction 10/2006

Drug/Important Bio-Agent (IBA)

3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2014 - 10/2006
2	Angiotensin IIIBA 04/2014 - 05/2010
2	AngiotensinsIBA 04/2011 - 10/2006
1	CollagenIBA 04/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2014
1	Proteins (Proteins, Gene)FDA Link 04/2014
1	rho-Associated KinasesIBA 04/2011
1	Antihypertensive Agents (Antihypertensives)IBA 04/2011
1	Protein Kinases (Protein Kinase)IBA 04/2011
1	Insulin (Novolin)FDA Link 05/2010
1	Cardiovascular AgentsIBA 05/2010
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2010
1	Peptides (Polypeptides)IBA 05/2010
1	angiotensin I (1-7)IBA 05/2010
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2010
1	Enalapril FDA LinkGeneric 10/2006
1	Messenger RNA (mRNA)IBA 10/2006
1	Angiotensin-Converting Enzyme 2IBA 10/2006

Therapy/Procedure

1	Ligation 10/2006